
A pandemic of the novel coronavirus has now infected more than 80.2 million people worldwide and killed over 1.7 million of them, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.

A pandemic of the novel coronavirus has now infected more than 80.2 million people worldwide and killed over 1.7 million of them, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.
The New York City health care provider under investigation for allegedly misappropriating the Moderna coronavirus vaccine, told ABC News it will return its vials to the state Health Department.
The New York State Department of Health is currently probing ParCare, which has offices in Brooklyn, to determine if it misused what was an approved allocation toward members of the public not yet prioritized under current New York guidelines.
Under the current state rules, only medical workers, first responders and nursing home staff members are allowed to receive any coronavirus vaccine. Other groups will follow in future rounds.
ParCare touted the vaccine on its social media pages with a flyer that claimed the vaccines would be available on a "first come, first serve basis."
"We have set up a special system where you can reserve your slot. This will enable you to receive the vaccine as soon as it arrives to the center," the flyer said.
The flyer also claimed that the vaccines were only for people who were "elderly," "high risk" or "underlying conditions."
New York state police and other investigators were at the ParCare location in Borough Park on Saturday night.
A spokesman for ParCare told ABC News Sunday evening that it is cooperating with the state investigation and will return its unused vials.
ParCare received 2,300 doses of the Moderna vaccine, and 869 of those doses have already been administered, according to the spokesperson.
"ParCare followed all NYS DOH procedures for obtaining the Moderna vaccine and was approved by NYS DOH for distribution and by CDC as a network site. As a result, we have properly received the vaccines and have provided the documentation regarding the proper receipt of the vaccines to the NYS DOH," the spokesperson told ABC News.
With regards to the patients who received their first shot, ParCare said it will be "working with the state to ensure that we provide the second dose for our patients."
-ABC News' Sasha Pezenik and Aaron Katersky contributed to this report
South African health officials announced Sunday the country recorded 9,502 new COVID-19 cases, bringing the nation's total case number to 1,004,413.
South Africa's Health Minister Dr. Zweli Mkhize also reported 214 new coronavirus fatalities, which brings the total death toll to 26,735.
The positivity rate was 32.2% Sunday, according to the health data.
The Africa Centres for Disease Control and Prevention announced last week that they discovered a new variant of the virus that "may be associated with increased transmissibility and a higher viral load than the previously circulating variants."
-ABC News' Christine Theodorou contributed to this report
New York state's coronavirus hospitalization numbers have jumped to a level not seen since the middle of May, according to data released Sunday by the state Health Department.
About 7,183 New Yorkers are hospitalized with COVID-19 symptoms statewide, the health data showed. New York's hospitalization numbers have been below 7,000 since May 11, according to the health data.
Statewide hospitalizations peaked at 18,825 on April 12, when New York was the epicenter of the pandemic in the U.S., the health data showed.
Although hospitalizations went down during the rest of the spring and summer, the state's hospitalization rate has been steadily increasing since Oct. 1, when there were 648 people hospitalized, the Health Department data showed.
There were 1,187 coronavirus patients in Intensive Care Units and 687 of them were intubated, the Health Department said.
The state peaked with 5,225 patients in ICUs on April 13, data showed.
Beijing government officials are tightening epidemic prevention measures after the first local COVID-19 infection in over five months was reported on Dec. 18. and the numbers continue to increase. on Sunday, China's National Health Commission reported 22 newly diagnosed cases, eight of which were in Beijing.
“There have been many sporadic outbreaks. The epidemic control situation is very severe,” a Beijing government spokesperson said on Sunday, according to the South China Morning Post. “All districts, all agencies and units must enter a state of emergency response and fight … with more resolution and stricter rules to prevent the spread of the coronavirus,” the spokesperson said.
Mass testing is in progress in two Beijing districts where new cases have been detected. By Saturday, at least 1,072,683 samples had been collected, according to the South China Morning Post.
Beijing government officials have imposed several control measures:
-Residents have been advised not to leave Beijing during the upcoming New Year and Spring Festival holidays.
-The city is imposing restrictions on entertainment venues and tourism to avoid gatherings during the holidays.
-Districts where new cases were identified were closed off, strict access controls are in place.
-Beijing travel agencies are banned from offering vacation packages to other cities in China where new COVID-19 cases have been reported.
-International travel has been banned.
-ABC News' Christine Theodorou
A person receiving the Moderna vaccine has had a serious allergic reaction apparently for the first time.
Dr. Hossein Sadrzadeh, a geriatric oncology fellow at Boston Medical Center, had the serious reaction when receiving the vaccine earlier this week.
"The employee received the Moderna vaccine Thursday and as is our standard practice was being observed post vaccination by trained nurses," Boston Medical Center said in a statement Friday. "He felt he was developing an allergic reaction and was allowed to self-administer his personal epi-pen. He was taken to the Emergency Department, evaluated, treated, observed and discharged. He is doing well today."

There have been a handful of reports about recipients of the Pfizer-BioNTech vaccine suffering allergic reactions, but this is the first known via Moderna's shot.
Sadrzadeh told ABC News that he specifically chose to get the Moderna vaccine -- as opposed to Pfizer's vaccine -- because he had a history of allergic reactions.
At the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices hearing last week discussing approval for the vaccine, Moderna scientist Dr. Jacqueline Miller discussed some cases in the trials.
"At the time of our EA submission, we've had two anaphylaxis reactions that have been reported as unsolicited and one was in a placebo group occurring 10 days after the first [shot]," Miller told the panel. "And that subject has reported a history of allergy to shellfish."
Sadrzadeh also had a shellfish allergy.
"They injected the vaccine, and just like less than a minute after injecting the vaccine, I felt that my heart is racing," he told ABC News late Friday. "I asked the nurses to come and just take my vital signs ... and interestingly, for the first time in my life, I saw my heart rate is 154. I felt like tingling, numbness in my tongue and also in my throat. It was like a similar feeling that I had before with my allergic reaction."
Sadrzadeh said his blood pressure was so low it did not register on the machine and at that point asked if he could inject himself with his EpiPen.

"It was not the first time that I had this experience, but I would say that it was the worst experience after my first experience at age 11," he added.
Dr. Anthony Fauci, the nation's foremost infectious disease expert, said people who are prone to these types of severe allergic reactions might want to get their vaccine at a medical facility that's equipped to take care of them, in case they experience a severe reaction.
ABC News' Zohreen Shah and Sean Sanders contributed to this report.